Analysts Anticipate 27% Gains Ahead For The Holdings of XHS

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Health Care Services ETF ( XHS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $62.28 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With XHS trading at a recent price near $48.86 per unit, that means that analysts see 27.46% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of XHS's underlying holdings with notable upside to their analyst target prices are Community Health Systems, Inc. ( CYH), Capital Senior Living Corp. ( CSU), and Cross Country Healthcare Inc ( CCRN). Although CYH has traded at a recent price of $4.66/share, the average analyst target is 106.33% higher at $9.62/share. Similarly, CSU has 32.31% upside from the recent share price of $14.36 if the average analyst target price of $19.00/share is reached, and analysts on average are expecting CCRN to reach a target price of $17.00/share, which is 30.47% above the recent price of $13.03. Below is a twelve month price history chart comparing the stock performance of CYH, CSU, and CCRN:

CYH, CSU, and CCRN Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
SPDR S&P Health Care Services ETF XHS $48.86 $62.28 27.46%
Community Health Systems, Inc. CYH $4.66 $9.62 106.33%
Capital Senior Living Corp. CSU $14.36 $19.00 32.31%
Cross Country Healthcare Inc CCRN $13.03 $17.00 30.47%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on CYH — FREE
Get the latest Zacks research report on CSU — FREE
Get the latest Zacks research report on CCRN — FREE

If you liked this article you might like

Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns

Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns

How Politics Is Influencing the Markets

How Politics Is Influencing the Markets

12 Best Biotech and Health Care ETFs to Add to Your Portfolio

12 Best Biotech and Health Care ETFs to Add to Your Portfolio